BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates

  Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today reported financial and operating results for the full year ended December 31, 2023 and presented corporate updates.

  February 28, 2024

   · 

  18 min read
• VahatiCor, Inc. Announces Treatment of the First Patient with the A-FLUX Reducer System®

  Innovation for patients suffering from angina due to persistent ischemic heart disease

  February 28, 2024

   · 

  3 min read
• Policy

  Koning Health Achieves UAE Regulatory Clearance, Paving the Way for Breast CT Commercialization in the Middle East

  Koning Health, a pioneering medical imaging company, is thrilled to announce that it has received regulatory clearance from the Federal Authority for Nuclear Regulation in the United Arab Emirates, marking a significant milestone in the company’s expansion and its commitment to global health innovation.

  February 28, 2024

   · 

  2 min read
• Genetown

  Ginkgo Technology Network Launches, Providing an Integrated R&D Experience with Capabilities from Over 25 Inaugural Partners

  Ginkgo Bioworks announced the creation of the Ginkgo Technology Network - a groundbreaking ecosystem of cutting edge technology partners, each committed to collaborating with Ginkgo to provide new, integrated capabilities to drive success in customer R&D programs.

  February 28, 2024

   · 

  19 min read
• Deals

  Ginkgo Bioworks Acquires Patch Biosciences, Expanding Suite of Genetic Medicine Capabilities Available to Customers

  Today, Ginkgo Bioworks announced the acquisition of Patch Biosciences, which has built an AI platform for sequence design that enables more effective, specific, and durable genetic medicines.

  February 28, 2024

   · 

  6 min read
• Business

  Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

  Xeris Biopharma Holdings, Inc. today announced that the Company will release its fourth quarter and full year 2023 financial results before the open of the U.S. financial markets on Wednesday, March 6, 2024.

  February 28, 2024

   · 

  2 min read
• Business

  Immunocore reports fourth quarter and full year 2023 financial results and provides a business update

  Immunocore Holdings plc today announced its financial results for the fourth quarter and year ended December 31, 2023 and provided a business update.

  February 28, 2024

   · 

  28 min read
• Business

  Sensei Biotherapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights

  Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today reported financial results for the full year 2023, and provided corporate updates.

  February 28, 2024

   · 

  12 min read
• Drug Development

  Spectral Medical Provides February Tigris Trial Update

  Spectral Medical Inc. today provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock.

  February 28, 2024

   · 

  3 min read
• Pharm Country

  Carisma Therapeutics to Participate in TD Cowen’s 44th Annual Health Care Conference

  Carisma Therapeutics Inc. today announced that Steven Kelly , President and Chief Executive Officer, will participate in the TD Cowen 44th Annual Health Care Conference.

  February 28, 2024

   · 

  1 min read